2026 Pharmaceutical Position Paper
In a comprehensive policy white paper addressed to the Taiwanese government, a specialized committee of industry stakeholders and policy experts has outlined a strategic roadmap aimed at fortifying Taiwan’s pharmaceutical…
Strengthening Taiwans Pharmaceutical Ecosystem AmCham Recommendations for National Health Insurance Reform and Global Competitiveness
The American Chamber of Commerce in Taiwan (AmCham Taiwan) has released a comprehensive set of policy recommendations aimed at fortifying the nation’s pharmaceutical supply resilience and ensuring the long-term sustainability…
Strengthening Taiwans Pharmaceutical Resilience and Global Competitiveness Through Strategic Policy Reform and International Collaboration
The Committee representing major stakeholders in the pharmaceutical sector has issued a comprehensive set of policy recommendations aimed at fortifying Taiwan’s healthcare infrastructure, ensuring the long-term sustainability of the National…
Strengthening Taiwans Pharmaceutical Resilience and Global Competitiveness through Strategic Policy Alignment and Innovation
As global geopolitical shifts and economic volatility continue to reshape the international healthcare landscape, the Committee representing leading pharmaceutical stakeholders has issued a comprehensive set of recommendations aimed at bolstering…
Strengthening Taiwan’s Pharmaceutical Ecosystem: AmCham Recommendations for National Health Insurance Reform and Global Competitiveness
The AmCham Taiwan Pharmaceutical Committee has issued a comprehensive set of policy recommendations aimed at bolstering Taiwan’s pharmaceutical supply resilience, ensuring the long-term sustainability of the National Health Insurance (NHI)…
2026 Pharmaceutical Position Paper
The Committee on Pharmaceutical Affairs has issued a comprehensive set of policy recommendations aimed at bolstering Taiwan’s pharmaceutical supply resilience, ensuring the long-term sustainability of the National Health Insurance (NHI)…












